December 13, 2024 03:12 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal

Pharmaceutical major AstraZeneca decides to withdraw Covid-19 vaccine citing 'commercial reasons'

May 08, 2024, at 03:13 pm

The maker of Covishield, AstraZeneca, has decided to withdraw its Covid-19 vaccine citing "commercial reasons".

AstraZeneca admits in court papers that its COVID-19 vaccine can cause rare side effects

Apr 30, 2024, at 02:24 pm

AstraZeneca has confirmed in court documents that its COVID-19 vaccine, developed in collaboration with the University of Oxford, can cause a rare side effect called thrombosis with thrombocytopenia syndrome (TTS), according to a report released in a British newspaper.

AstraZeneca appoints Ram Mudaliar as India Lead of its Clinical Data & Insights Division

Jan 21, 2022, at 05:23 am

Bengaluru/IBNS: AstraZeneca India Private Limited, the services arm of AstraZeneca, a science-led biopharmaceutical company, on Thursday announced the appointment of Ram Mudaliar as the India lead of their Clinical Data & Insights (CDI) division.

India warns 'reciprocal measures' on UK vaccine policy

Sep 21, 2021, at 10:32 pm

New Delhi/IBNS: India has iterated its "right to take reciprocal measures" over the UK government's "discriminatory" decision to not recognise Covishield if the matter was not resolved, the government said Tuesday.  

Thai scientists develop robotic arm to draw more AstraZeneca vaccine doses

Aug 26, 2021, at 01:36 am

Bangkok: As Thailand fights its worst-ever Covid-19 outbreak, the scientists in the country have developed a robotic arm that can optimise the use of the coronavirus vaccines, enabling more efficient use of the doses.

Germany to give away 1.3 billion leftover AstraZeneca doses: Health Minister

Aug 05, 2021, at 01:05 am

Berlin/UNI/Sputnik: Germany will hand over 1.3 billion AstraZeneca vaccine doses to the COVAX shot-sharing mechanism, Health Minister Jens Spahn said.

Serum Institute says Covishield production increased to 110 million doses in July

Jul 13, 2021, at 11:39 pm

Pune/IBNS: Serum Institute of India (SII) said Tuesday the production of Covishield has been ramped up to 110 million doses this month, according to media reports.

AstraZeneca partners with Docon to digitise healthcare clinics across India

Jun 30, 2021, at 11:30 pm

Bengaluru, India: AstraZeneca India, a leading science-led biopharmaceutical company, on Wednesday announced that they have signed and memorandum of understanding with Docon Technologies, Bengaluru, for digitising 1,000 clinics across India.

Japan to supply COVID-19 hit Taiwan with 1.24 million doses of AstraZeneca shots

Jun 04, 2021, at 09:42 pm

Tokyo: Japan might extend help to Taiwan by supplying 1.24 million doses of the COVID-19 vaccine developed by Britain’s AstraZeneca PLC.

Ceasing their 2016 distribution deal Sun Pharma and AstraZeneca Pharma enter into a transition supply agreement

May 29, 2021, at 01:17 am

Mumbai/UNI: AstraZeneca India and Sun Pharma have now discontinued their distribution agreement signed in 2016 and have entered into a transition supply agreement with effect from today.

AstraZeneca-Oxford and Pfizer vaccines provide over 80 pc protection against Covid variant first found in India

May 23, 2021, at 06:53 am

London/IBNS: Two doses of AstraZeneca vaccine or Pfizer vaccine can give more than 80 per cent protection from the B1.617.2 variant of coronavirus first found in India, a new study conducted by the UK government has revealed, media reports said.

Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

May 21, 2021, at 08:05 pm

London: Two doses of the  AstraZeneca Plc's Covid-19 vaccine is providing   around 85 to 90% protection against symptomatic disease, as per statistics released by Public Health England on Thursday.

Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

May 21, 2021, at 05:15 pm

London: Two doses of the  AstraZeneca Plc's Covid-19 vaccine is providing   around 85 to 90% protection against symptomatic disease, as per statistics released by Public Health England on Thursday.

Study finds AstraZeneca vaccine works as third booster shot: Reports

May 19, 2021, at 11:47 pm

Moscow/Sputnik: A study conducted by Oxford university found that the AstraZeneca COVID-19 vaccine works best as a third dose for patients by boosting a vaccinee's antibodies to the virus, Financial Times reported.

Denmark permanently drops AstraZeneca vaccine's use over rare side effects

Apr 15, 2021, at 02:23 am

Denmark/IBNS: Denmark on Tuesday announced it would stop using the AstraZeneca Covid-19 vaccine permanently, becoming the first European country to do so over suspected rare but serious side effects.

South Korea to resume administration of AstraZeneca vaccines: Reports

Apr 11, 2021, at 09:11 pm

Moscow/Sputnik: South Korea decided on Sunday to resume the administration of AstraZeneca vaccines to suitable recipients after having paused distribution amid blood clot concerns, media reported.

UK to offer AstraZeneca vaccine's alternative to people below 30 yrs over concerns of blood clots

Apr 08, 2021, at 04:27 am

London/IBNS: Amidst concerns over rare blood clot disorders resulting in deaths of people following inoculation, a government committee in the UK has said that those below 30 years of age should be offered an alternative to the AstraZeneca Covid vaccine.

COVID-19: AstraZeneca vaccine benefits still ‘largely positive’

Apr 07, 2021, at 10:26 pm

New York: The benefits of the AstraZeneca COVID-19 vaccine are still “largely positive” and outweigh risk of rare but serious blood clots, according to an official with the World Health Organization (WHO), speaking on Tuesday during the agency’s regular press briefing from Geneva.

Oxford suspends dosing in trial of AstraZeneca COVID vaccine in children, teenagers

Apr 07, 2021, at 02:02 pm

London/Sputnik: The University of Oxford said it had suspended administering doses of the vaccine against the novel coronavirus disease (COVID-19) it developed with AstraZeneca in a UK study on children and teenagers aged 6-17, The Wall Street Journal (WSJ) reported.

WHO may update safety assessment of AstraZeneca vaccine in two days: Official

Apr 07, 2021, at 05:22 am

Geneva/UNI: The World Health Organization (WHO) may update its safety assessment on the AstraZeneca COVID-19 vaccine within the next two days, informed an official on Tuesday.

UK records 30 thrombosis cases after vaccination with AstraZeneca drug: Medicines Agency

Apr 02, 2021, at 01:52 pm

Moscow/Sputnik: The United Kingdom has registered 30 cases of blood clots following the vaccination with the AstraZeneca drug, the Medicines and Healthcare Products Regulatory Agency said.

Spanish Health Ministry lifts age restrictions for AstraZeneca vaccine: Reports

Mar 31, 2021, at 02:53 pm

Madrid/Sputnik: The Spanish Health Ministry is lifting the age restrictions for the coronavirus vaccine produced by AstraZeneca, Cadena Ser radio reported.

Denmark registers 2nd death after AstraZeneca COVID-19 shot: Reports

Mar 21, 2021, at 03:23 pm

Murmansk, Russia/Sputnik: A second person has died in Denmark shortly after receiving the AstraZeneca COVID-19 vaccination, national media reported on Saturday.

AstraZeneca Covid vaccine safe, works extremely well: Boris Johnson

Mar 17, 2021, at 02:42 am

New Delhi/IBNS: British Prime Minister Boris Johnson on Tuesday came out in support of AstraZeneca coronavirus vaccine after several European countries temporarily halted the use of the shot, following reports of blood clots in people who received the vaccine from two batches.

COVID-19: WHO and European Medicines Agency to meet on AstraZeneca vaccine

Mar 16, 2021, at 09:53 pm

New York: Health officials from the UN and the European Union will meet this week on the AstraZeneca COVID-19 vaccine after several more countries suspended its use, the head of the World Health Organization (WHO) said on Monday.

WHO to hold meeting on AstraZeneca Vaccine safety on Tuesday

Mar 16, 2021, at 02:42 pm

Geneva/Sputnik: The World Health Organization's (WHO) global advisory committee on vaccine safety will hold a meeting on Tuesday on the safety of the AstraZeneca vaccine, WHO Director General Tedros Adhanom Ghebreyesus said.

AstraZeneca Confirms Shortfall in Planned COVID-19 Vaccine Shipments to EU

Mar 14, 2021, at 01:30 am

Moscow/Sputnik: UK-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has confirmed a shortfall in shipments of its COVID-19 vaccine to the European Union.

Australia receives first batch of AstraZeneca vaccines: Health Minister

Feb 28, 2021, at 09:25 pm

Moscow/Sputnik: The first shipment of COVID-19 vaccines developed by UK drugmaker AstraZeneca arrived in Australia on Sunday, Australian Health Minister Greg Hunt said.

AstraZeneca vaccine will work better, faster if 2nd dose replaced with Sputnik V:Makers

Feb 20, 2021, at 10:37 pm

Moscow/Sputnik: Developers of Russia's Sputnik V coronavirus vaccine said on Saturday that AstraZeneca can achieve maximum efficacy of its vaccine in less than a three-month interval if it uses Sputnik V as its second shot.

AstraZeneca COVID jab 'less effective against South Africa variant': Reports

Feb 08, 2021, at 12:04 am

Johannesburg/UNI: According to reports the COVID-19 vaccine developed by AstraZeneca and the University of Oxford offers only limited protection against the South African variant of the coronavirus, a spokesman for the British drugmaker said here on Sunday.